Compare EVO & TBLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVO | TBLA |
|---|---|---|
| Founded | 1993 | 2007 |
| Country | Germany | United States |
| Employees | 4553 | 2000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 952.2M |
| IPO Year | N/A | N/A |
| Metric | EVO | TBLA |
|---|---|---|
| Price | $3.07 | $4.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $7.00 | $5.00 |
| AVG Volume (30 Days) | 47.1K | ★ 3.2M |
| Earning Date | 04-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.37 | $7.63 |
| Revenue Next Year | $10.05 | $5.25 |
| P/E Ratio | ★ N/A | $42.36 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.31 | $2.84 |
| 52 Week High | $4.42 | $5.26 |
| Indicator | EVO | TBLA |
|---|---|---|
| Relative Strength Index (RSI) | 56.03 | 63.27 |
| Support Level | $2.88 | $3.94 |
| Resistance Level | $3.75 | $5.26 |
| Average True Range (ATR) | 0.07 | 0.18 |
| MACD | 0.01 | -0.05 |
| Stochastic Oscillator | 89.58 | 26.53 |
Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.
Taboola is a performance-based native advertising network designed to improve click-through rates and increase monetizable events for advertisers while generating yield for publisher websites. Taboola competes with Google, Amazon, and other advertising networks that display stories and products on websites. The company was founded in 2007 in Israel. It acquired Connexity, a retail advertising network, in 2021, and entered a partnership with Yahoo in 2022, in which it acquired exclusive native advertising rights over Yahoo digital properties in exchange for a 25% equity stake in the company.